CerMed International acquires Viridis Bioscience - MarketLine Financial Deals

CerMed International acquires Viridis Bioscience

CerMed International acquires Viridis Bioscience - MarketLine Financial Deals
CerMed International acquires Viridis Bioscience
Published Mar 10, 2011
2 pages — Published Mar 10, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

CerMed International, Inc., a medical device company that develops products and systems that help improve the health of women, has acquired Viridis Bioscience.

  
Source:
Document ID
MA64124_110530
Country
Ticker
GMS=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "CerMed International acquires Viridis Bioscience" Mar 10, 2011. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CerMed-International-acquires-Viridis-Bioscience-2052-61545>
  
APA:
MarketLine Financial Deals. (2011). CerMed International acquires Viridis Bioscience Mar 10, 2011. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CerMed-International-acquires-Viridis-Bioscience-2052-61545>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.